Frontier Wealth Management LLC Amgen Inc Transaction History

Frontier Wealth Management LLC

$8.02 Billion
Q2 2022

A detailed history of Frontier Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Frontier Wealth Management LLC holds 44,815 shares of AMGN stock, worth $12.3 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

44,815

Previous 44,815 -0.0%

Holding current value

$12.3 Million

Previous $11.2 Million -0.0%

% of portfolio

0.14%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $6,921 - $7,702	-30 Reduced 0.07%	44,785 $10.9 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $53,721 - $59,429	245 Added 0.55%	44,815 $11.2 Million
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $1.02 Million - $1.16 Million	5,114 Added 12.96%	44,570 $10 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $726,387 - $851,051	-3,422 Reduced 7.98%	39,456 $8.39 Million
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $35,971 - $39,907	-154 Reduced 0.36%	42,878 $10.5 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $24,410 - $28,446	110 Added 0.26%	43,032 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $135,670 - $161,559	627 Added 1.48%	42,922 $9.87 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $351,975 - $391,425	-1,500 Reduced 3.43%	42,295 $10.8 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $160,819 - $197,347	813 Added 1.89%	43,795 $10.3 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $2.8 Million - $3.72 Million	15,384 Added 55.74%	42,982 $8.71 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $3.08 Million - $3.96 Million	-16,298 Reduced 37.13%	27,598 $6.65 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $256,464 - $307,297	-1,473 Reduced 3.25%	43,896 $8.49 Million
Q2 2019 Aug 16, 2019	SELL	$166.7 - $195.41 $131,192 - $153,787	-787 Reduced 1.71%	45,369 $8.36 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $61,134 - $68,911	338 Added 0.74%	46,156 $8.77 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $63,153 - $73,720	354 Added 0.78%	45,818 $8.92 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $535,488 - $603,692	-2,890 Reduced 5.98%	45,464 $9.42 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $169,537 - $190,426	-1,021 Reduced 2.07%	48,354 $8.93 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1.36 Million - $1.59 Million	-8,025 Reduced 13.98%	49,375 $8.42 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $16,203 - $18,104	-96 Reduced 0.17%	57,400 $9.98 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $262,812 - $300,061	-1,571 Reduced 2.66%	57,496 $10.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	59,067	59,067 $10.2 Million

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.

Account

Frontier Wealth Management LLC Amgen Inc Transaction History